CompletedPhase 1NCT01808820

Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Studying Anaplastic astrocytoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Macarena De La Fuente, MD
Principal Investigator
Macarena De La Fuente, MD
University of Miami
Intervention
Dendritic Cell Vaccine(biological)
Enrollment
20 enrolled
Eligibility
13-99 years · All sexes
Timeline
20132022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01808820 on ClinicalTrials.gov

Other trials for Anaplastic astrocytoma

Additional recruiting or active studies for the same condition.

See all trials for Anaplastic astrocytoma

← Back to all trials